Actively Recruiting
Evaluating Permissive Lung-Protective Ventilation Versus Conventional Ventilation in Critically Ill Adults Receiving Invasive Mechanical Ventilation
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2026-09-23
926
Participants Needed
2
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a ventilation method called permissive lung-protective ventilation in adult critically ill patients who need invasive ventilation. This study compares this method, which lowers the respiratory rate stepwise within safety limits, to the conventional lung-protective ventilation. The main goal is to see if the new method increases the number of days patients are alive and free from ventilation by day 28. Participants are randomly assigned to one of two groups one receives permissive lung-protective ventilation where the respiratory rate is gradually reduced guided by blood gas measurements and safety limits for carbon dioxide and pH the other receives conventional lung-protective ventilation with respiratory rates set to standard care targets. Both groups follow lung-protective ventilation guidelines, and the stepwise reduction in respiratory rate for the permissive group is completed within 4 to 6 hours after starting. During the trial, participants are closely monitored with arterial blood gas analyses and clinical assessments. Researchers measure outcomes including the number of days free from ventilation and alive at day 28, duration of ventilation, mortality at 28 and 90 days, length of intensive care and hospital stay, and rates of complications such as acute respiratory distress and kidney injury. The study lasts until day 28 for primary outcomes, with follow-up for up to 90 days for some measures. Data collection involves standard care procedures and no additional invasive interventions beyond routine blood sampling.
CONDITIONS
Brief Title
PERMISSive Lung-protective Ventilation RCT
Research Team
L
Laura A. Buiteman-Kruizinga, PhD
A
Amarens Hoogenboom, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here